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1. Introduction
  The gap junction (GJ), which is located between myocardial cells, 
provides a direct communication pathway between ions and small 
molecular substances, to mediate intercellular communication. As 
the neighboring cells uncouple, the connecting channel of the gap 
closes, and subsequently induce slow and heteroplasmic electrical 
conductions that easily promote arrhythmia[1]. Cx43 is a major 
ventricular GJ protein, and its functional status is regulated based 
on the state of phosphorylation. Previous studies showed that Cx43 
dephosphorylation may have an active role during the GJ channel 
closing process[2-5].
  Antiarrhythmic peptide (AAP)[3] was named from its potent 
antiarrhythmic effects. In the AAP family, AAP10 has the same 
pharmacological effect[4]. Stains et al[5] considered the eliciting 
anti-arrhythmic effects of AAP10 through enhancing electrical 
conduction between the GJ. However, there was no uniform 
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conclusion pertaining to the mechanisms involved in enhancing 
electrical conduction. Li et al[6] speculated that AAP10 may have 
some protective effect on the Cx43 expression. AAP10 can reduce 
the rate of incidence of arrhythmia through adjusting the P-Cx43 
concentration. However, this viewpoint still falls short of sufficient 
experimental validation. To further explore the effects of AAP10 on 
acute ventricular arrhythmia, the author and his team established 
isolated acute cardiac ischemia SD rat models, and explored the 
possible mechanisms of the antiarrhythmic effects of AAP10 
on acute ventricular arrhythmia from the Cx43 phosphorylation 
perspective.
2. Materials and methods
2.1. Experimental animals and equipment
  A total of 60 SD rats, half male and half female, were provided by 
the Experimental Animal Center of Shanghai Traditional Chinese 
Medicine University, weighing (300依50) g. The rats were initially 
anesthetized with 3% sodium pentobarbital 30 mg/kg (US Biotopped 
Co.), and treated with 250 毺/kg heparin (Shanghai Fudan Fuhua 
Pharmaceutical Co., Ltd.), as an anticoagulant. After anesthesia, the 
costal margin of the abdominal wall below the xiphoid process was 
explored, and the diaphragm was cut open. The chest wall was cut 
along the anterior axillary line, turning up to the side of the head. 
Three branches of the aortic arch were clamped by micro surgery 
forceps. The aorta (retaining     3-4 mm from the root of heart), 
pulmonary artery, pulmonary vein, and inferior vena cava were 
rapidly interrupted. After exposure of the aortic arch, the complete 
heart was cut along the aortic stump, which was cut below aortic 
arch. The heart was cut off and was placed into an ice-cold Kreb-
Henseleit (K-H) solution (4 曟); residual blood was gently washed 
away. The edges of the ascending aorta were clamped with two 
micro-surgical forceps. The filling canals of the aorta were inserted, 
fixed by an artery clamp, and the Langendorff perfusion device (AD 
Instruments Pty Ltd, Australia) was rapidly connected, and fixed 
by line 0. It was then perfused with a modified K-H buffer, and 
saturated with 95% O2 and 5% CO2. The perfusion fluid temperature 
was kept at 37 曟 with a PH value of 7.4. During the experiment, the 
perfusion pressure was kept at 80-100 cmH2O and the perfusion flow 
was 8-10 mL/min. After the heart perfusion model was successfully 
established, the isolated heart started to re-beat within seconds. 
When the heart re-started and cardiac functions became stable, 
a pressure-measuring catheter balloon was inserted into the left 
ventricle through the mitral valve, and the other end of the pressure-
measuring catheter was connected to Multi physiological recorder 
through pressure sensor.
  A 0.3 mm diameter silver wire was used as a pair of electrodes to 
record the epicardial electrical diagram; the lead wire was connected 
to the physiological recorder (Shanghai Alcott Biotechnology Co., 
Ltd.). One of the electrodes was fixed at the right ventricular free 
wall, the another electrode was fixed at the left ventricular free 
wall[6].
The ischemia animal model was established by ligating the left 
anterior descending artery (LAD). Between the left atrial appendage 
and arterial cone, a wire was used to bypass the LAD; both ends of 
wire were passed through a hollow plastic tube, which was ligated 
on another short rubber hose. Myocardial ischemia was induced, and 
it was observed for 30 minutes.
2.2. Experimental scheme
2.2.1. Grouping and establishment of ischemia-reperfusion 
model 
  Rats in control group (Control) and total ischemia group (TI) 
received isolated heart infusion for 30 minutes, then perfusion was 
stopped for 30 min. Rats in partial ischemia group (PI) received 
isolated heart infused for 30 minutes, then regional ischemia was 
induced by ligating LAD for 30 minutes. After 15 minutes of 
pretreatment, rats in AAP10 total ischemia (ATI) group were treated 
with perfusion fluid containing 1 mg/L concentration of AAP10 for 
another 15 minutes, and perfusion was stopped for 30 minutes. Rats 
in AAP10 partial ischemia (API) group were treated with perfusion 
fluid containing 1 mg/L AAP10 concentration for another 15 
minutes, then regional ischemia was induced by ligating LAD for 30 
minutes.
  After pretreatment, the heart was isolated in a K-H solution for 15 
minutes; and the stability of the cardiac functions was measured. 
Time was set to 0 min at the beginning of the experiment. The 
heart was treated with different perfusion fluids, according to the 
different groups; then perfusion was stopped to induce total heart 
ischemia or ligated LAD to induce a partial ischemia (except the 
control group) for 30 minutes. The experiment was stopped when 
there was continuous ventricular tachycardia (>1 min) or ventricular 
fibrillation. The control group did not receive any intervention, and 
the other processes were the same as above.
2.2.2. Detection of the protein expression 
  After perfusion in the partial ischemia group, the Evans blue dye 
test was carried out. The aizen area represented the non-ischemic 
area, and the undyed area represented the ischemic area. TTC 
stain was carried out to the cardiac muscle at the undyed area; 
the red area represented the ischemic area, and the unstained area 
represented the infarct area. Myocardial ischemia was detected by 
immunofluorescence staining and analyzed by a laser scanning 
confocal microscope. The hearts from the control group were 
directly detected by the above method at the LAD perfusion area.
  Western blot detection was also carried out on the myocardial 
of the groups at the same time. A total of 100 mg of myocardial 
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tissues were obtained from each group. After cryogenic grinding 
with liquid nitrogen, 1 mL RIPA Lysis buffer (NanJing SunShine 
Biotechnology Co., LTD) was added for tissue lysis. Protein was 
obtained, after 2 minutes of high speed centrifugation at 12 000 g. A 
small amount of supernatant was used for quantitative measurement. 
The protein samples were adjusted to equal the concentrations. After 
polyacrylamide gel electrophoresis, the membrane was transferred 
and prepared for blocking. Primary antibodies were added and 
washed; secondary antibodies were added and washed again. Scan 
and analysis was carried out after luminescence identification.
2.3. Statistical analysis
  All data were analyzed by SSPS19.0 statistics software, and the 
data were expressed as mean依SD values. t-test was applied in 
comparing the two groups. 氈
2 test was used to count the data; 
P<0.05 was considered as significant difference.
3. Results
3.1. Results of the Langendorff isolated perfused SD rat 
models
  The number of cases that occurred during the ischemic period, 
as well as the number of ventricular tachycardia and ventricular 
fibrillation cases for each group is shown in Table 1. During the 
ischemic stage, the rate of incidence for arrhythmia in the ATI and 
API groups (10% and 0%) were lower than the TI and PI groups 
(60% and 45%). The difference was statistically significant between 
the two groups (P = 0.019, P = 0.020).
      
3.2.  Protein expression results
  he relative gray values of the total-Cx43 protein bands for the TI 
and PI groups were lower than the control group. The relative gray 
values of the total-Cx43 protein bands for the ATI and API groups 
were lower than the TI and PI groups. The relative gray values of the 
NP-Cx43 protein bands for the TI and PI groups were higher than 
the control group. The relative gray values of the NP-Cx43 protein 
bands for the ATI and API groups were lower than the TI and PI 
groups. All of the differences were statistically significant (P<0.05) 
(Figure 1). 
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Figure 1. Ischemia myocardial Western blot results. 
Figure 1A shows the protein band of the Western blot. The upper figure 
represents the protein band of NP-Cx43, the middle figure represents the 
protein band of total-Cx43 and the lower figure represents the protein band 
of the GAPDH gene. GAPDH gene serves as an internal reference. Figure 
1B shows the relative gray values of the total-Cx43 protein band. Figure 1C 
shows the relative gray values of the NP-Cx43 protein band. The gray-scale 
value of the control group is 1, and gray-scale values of the other groups are 
values which were compared with the control group. 
Table 1 
Effects of AAP10 on the number of ventricular tachycardia and ventricular fibrillation cases.
Groups Cases in ischemic period Ventricular tachycardia and Ventricular fibrillation Incidence of arrhythmia(%) 氈
2 P value
Control group 12 0   0 -- --
TI group 10 6 60 9.900 0.002
ATI group 10 1 10 1.257 0.262
PI group 11 5 45 6.970 0.008
API group   9 0   0 -- --
Note: TI group compared with the ATI group, P = 0.019, 氈
2 = 5.495; PI group compared with the API group, P = 0.020, 氈
2 = 5.455.
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  In the TI and PI groups, total-Cx43 was decreased in number, but 
NP-Cx43 was increased in number. For the ATI and API groups, the 
fluorescence signal intensity of total-Cx43 was stronger than the 
TI and PI groups, while the signal intensity of NP-Cx43 was lower 
than the TI and PI groups (Figure 2). The semi-quantitative analysis 
results of Cx43 are shown in Table 2. 
Conrtol Group A                                                   B                                     C
TI Group D                                                       E                                          F
ATI Group G                                                      H                                          I
PI Group J                                                       K                                          L
API Group M                                                    N                                      O
Figure 2. Immunofluorescence staining results of the ischemia myocardial 
by laser scanning confocal microscope (×400). 
The NP-Cx43 in figures B, E, H, K, and N are labeled by green fluorescent. 
The total-Cx43 in Figures C, F, I, L, and O are labeled by red fluorescent. A, 
D, G, J, M are fusion figures.
Table 2 
Cx43 semi-quantitative analysis results (毺m
2).
Groups Total-Cx43 NP-Cx43
Control group 1 706依397 250依190
TI group     561依147*  440依210*
ATI group  1 027依215*  330依116*
PI group     702依155*  602依115*
API group  1 112依301*  420依124*
Note: compared with the control group, *P< 0.05.
  Compared with the control group, the number of total-Cx43 in 
the TI, ATI, PI and API groups was significantly decreased; while 
the number of NP-Cx43 was significantly increased. Both of the 
differences were statistically significant (P<0.05). This suggests that 
GJ functions was reduced with the decrease of P-Cx43, which may 
induce ischemic ventricular arrhythmias. AAP10 could partially 
reverse the extent of total-Cx43 reduction and reduce the number 
of NP-Cx43, thus, maintain the quantity of P-Cx43 protection and 
improve the GJ function, which may reduce ischemic ventricular 
arrhythmias.
4. Discussion 
  AAP obviously has an anti-arrhythmic effect; but its specific 
effects and mechanisms are still unclear. GJ play an important role 
in maintaining normal heart rhythm and in the material exchange 
process between cells[7-14]. This study applied isolated perfusion 
experiments to explore the effects of AAP10 on acute ventricular 
arrhythmia, and the relationship of AAP10 with the Cx-43 protein of 
the GJ. This research clearly shows the mechanism of AAP10 and 
provides new ideas for the prevention and treatment of ventricular 
arrhythmia.
4.1. Effect of AAP10 on ischemic arrhythmias
  In this study, the rate of incidence of ventricular arrhythmias 
occurred to nearly half of the 21 animals for the TI and PI groups, 
and occurred only once among 19 animals for the ATI and API 
groups. These results suggest that AAP10 can significantly decrease 
the incidence rate of acute ischemia-induced ventricular tachycardia 
and ventricular fibrillation; AAP10 can increase the expression of 
total-Cx43 and decrease the expression of NP-Cx43, specifically 
increasing the quantity of functional P-Cx43. This effect may 
improve and restore the consistency of electrical conductions 
between cells; which could be good for breaking the reentrant 
loop and suppressing the occurrence of ventricular fibrillation and 
ventricular tachycardia[15].
4.2. Relationship of Cx43 and arrhythmia
  From the results of this study, Cx43 phosphorylation and Cx43 
dephosphorylation were both found on normal myocardial 
cellular surfaces. The ischemic results of the Western blot and 
immunofluorescence staining tests revealed a decrease in total-
Cx43 and an increase in NP-Cx43 quantities; these results mean 
that the functional P-Cx43 levels also decreased, which were 
related to previous studies[15,16]. Last 2000, Verrier et al[16] found 
that P-Cx43 levels decreased and NP-CX43 levels increased due to 
ischemia aggravation in the acute ischemic myocardial tissues. In 
this experiment, either total heart ischemia or partial ischemia can 
increase the occurrence of ventricular fibrillation and ventricular 
tachycardia. This suggests that due to the probable decrease of 
P-Cx43, the GJ function was reduced in acute myocardial ischemia; 
which slowed down the electrical conduction speed of myocardial 
cells, thus, forming a material foundation for reentrant arrhythmia; 
and malignant arrhythmia, such as ventricular tachycardia and 
ventricular fibrillation, were prone to accrue. Some studies showed 
that inhibiting GJ functions have some effect on arrhythmias[17-19].
  The experimental results revealed that total-Cx43 in the ischemic 
myocardium significantly reduced, compared to that of the normal 
myocardium, which suggests that myocardial ischemia damaged 
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the existing GJs. There are several possible mechanisms involved 
in this process, such as intracellular accumulation of acidic 
substances, large generation of oxygen free radicals, gathering of 
lipid metabolites, etc. The decreased Cx43 phosphorylation level 
and myocardial ischemia can cause intracellular ATP hydrolysis; 
wherein, the number of ATP cases dropped significantly, leading 
to connexin dephosphorylation. The reduced total-Cx43 and 
phosphorylation levels are signs of myocardial injury and protective 
responses of the heart. Studies have reported that in myocardial 
necrosis, harmful substances can pass through the GJs between the 
cells and expand the ischemic necrosis area[20,21]. The decreased 
values and functions of GJs is a self-limiting response, when damage 
increases up to a certain extent[22,23].
4.3. Deficiency and prospect of this paper
  Although the result of the experiment was satisfactory, there are 
still some shortcomings in the experimental process: first of all, the 
sample size was small. With limited funds and more groupings, the 
sample size in each group became smaller. Excluding ligation failure, 
10 out of 12 cases were effective in each group. A small sample size 
may cause bigger errors, therefore, the results obtained from this 
study does not have enough representation. In future experiments, 
we should enlarge the sample size, as well as increase the number 
of groups and the sample size in each group, in order to achieve a 
more objective and accurate result. Secondly, this study explored 
the antiarrhythmic mechanisms of AAP10 in acute ischemia from 
the Cx43 phosphorylation perspective, but no further study was 
done on the mechanisms that pertain to the regulation of AAP10 in 
Cx43 phosphorylation. Existing experimental results have confirmed 
that there is a connection between AAP10 and Cx43, therefore, the 
interaction mechanism between them deserves careful study. In the 
future, additional studies can be carried out to explore the relative 
mechanisms between these, and provide new ideas for developing 
new anti-arrhythmic drugs.
4.4.  Conclusion
  In summary, AAP10 can significantly decrease the rate of 
incidence of acute ischemia-induced ventricular tachycardia and 
ventricular fibrillation. In acute myocardial ischemia, myocardial 
cell intercellular communication slows down based on the 
decreased quantity of total-Cx43 and the changes on the state of 
phosphorylation. AAP10 may play its role by promoting Cx43 
phosphorylation and increasing the quantity of total-Cx43. However, 
the specific regulating mechanism of GJ phosphorylation is still not 
that clear, and needs to be further explored.
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